Recent Blog Posts

View Post: Dienekes' Anthropology Blog: European population substructure and ...
25 Oct 2009 by dienekesp  
Previous work has demonstrated that Northern and Southern European ancestries are associated with specific systemic lupus erythematosus (SLE) manifestations. In this study, 1855 SLE cases of European descent were genotyped for 4965 ...
View Blog: Dienekes' Anthropology Blog - http://dienekes.blogspot.com/

---

View Post: NAC for Systemic Lupus Erythematosus
6 Nov 2009 by jarebe  
The National Center for Complementary and Alternative Medicine at the NIH is funding a study at Upstate Medical University (Syracuse, NY) on the use of N-acetylcysteine (NAC) for Systemic lupus erythematosus (SLE). ...
View Blog: New York Buyers' Club - The Blog - http://nybc.wordpress.com/

---

View Post: The Complexity of Systemic Lupus Erythematosus
4 Nov 2009 by Healthy Life  
Systemic lupus erythematosus is a life-threatening chronic autoimmune disease. Although the mortality rate of patients with systemic lupus erythematosus has reduced in the last decades, the disease continues to raise serious problems to ...
View Blog: Medicrit - Medicare - http://www.medicrit.org/

---

View Post: ISPUB - Systemic lupus erythematosus and pregnancy: Today's scenario
19 Oct 2009
Systemic Lupus Erythematosus (SLE) is a rare disease, but the fact to be well appreciated is that 90% of the patients are females, that too of the reproductive age. Years ago, all medical texts said that lupus patients could not have ...
View Blog: Internet Scientific Publications - http://www.ispub.com/

---

View Post: Health awareness - » Management of systemic lupus erythematosus (SLE)
28 Oct 2009 by Dr.Irham  
Management for systemic lupus erythematosus (SLE) can be divided into pharmacological and non pharmacological. For non pharmacological, it will involve more on counseling and social support. SLE is a systemic disease that involve with a ...
View Blog: Health Aware - http://healthaware.eimsnetwork.com/

---

View Post: Benlysta update - good news all around!
4 Nov 2009 by Sara Gorman  
Human Genome Sciences announced that its drug BENLYSTA™ (belimumab) met its primary endpoint in BLISS-76, the second and final Phase 3 trial in seropositive patients with systemic lupus erythematosus (SLE). ...
View Blog: Despite Lupus - http://despitelupus.blogspot.com/

---

View Post: Expression of matrix metalloproteinase-1 mRNA in peripheral blood ...
5 Nov 2009 by ZHANG Hai-ying, BAO Shu-meng, SHOU Wei-ling,...  
This study was to examine expression of MMP-1 mRNA in peripheral blood mononuclear cells (PBMCs) of patients with systemic lupus erythematosus (SLE), and to explore its relationship with atherosclerosis in SLE. ...
View Blog: Chinese Medical Journal 2009 Vol. 122 No.21... - http://www.cmj.org/

---

View Post: CNS LUPUS
3 Nov 2009 by Administrator  
November 3, 2009 — The most general lesion in SLE is a vasculopathy characterized by fibrinoid necrosis primarily involving small arteries, arterioles, and capillaries. Interstitial collagen and membranes such as pleura, serosa, ...
View Blog: Eneurology - http://yassermetwally.com/blog/

---

View Post: Endpoints reached in second of two Phase 3 studies of Benlysta for ...
2 Nov 2009
Human Genome Sciences and GlaxoSmithKline announced that Benlysta (belimumab, formerly LymphoStat-B) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus ...
View Blog: Latest articles from MPR News - http://www.empr.com/

---